References
- Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev 2012;70:257–265
- Akar A, Arca E, Erbil H, et al. Antioxidant enzymes and lipid peroxidation in the scalp of patients with alopecia areata. J Dermatol Sci 2002;29:85–90
- Abdel Fattah NSA, Ebrahim AA, El Okda ES. Lipid peroxidation/antioxidant activity in patients with alopecia areata. J Eur Acad Dermatol Venereol 2011;25:403–408
- Bodemer C, Peuchmaur M, Fraitaig S, et al. The role of cytotoxic T-cells in chronic alopecia areata. J Invest Dermatol 2000;114:112–116
- Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol 2007;46:121–131
- Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549–566
- McDonagh AJ, Messenger AG. Alopecia areata. Clin Dermatol 2001;19:141–147
- McDonagh AJ, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 2002;27:405–409
- Naziroglu M, Kokcam I. Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct 2000;18:169–173
- Koca R, Armutcu F, Altinyazar CH, Gurel A. Evaluation of lipid peroxidation, oxidant/antioxidant status, and serum nitric oxide levels in alopecia areata. Med Sci Monit 2005;11:296–299
- Eken A, Dogan P, Karaoglu S, et al. Selenium and glutathione peroxidase in patients with alopecia. Turkderm 1996;30:23–34
- Gungor S, Akbay G, Ogus E, et al. Changes of lipid peroxidation and antioxidant system in serum and tissues of patients with alopecia areata. Turkiye Clin J Dermatol 2008;18:141–145
- Blatter MC, James RW, Messmer S, et al. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993;211:871–879
- Canales A, Sanchez-Muniz FJ. Paraoxanase something more than an enzyme? Med Clin (Barc) 2003;121:537–548
- Mackness MI, Durrington PN. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 1995;115:243–253
- Mackness MI, Abbott C, Arrol S, Durrington PN. The role of high density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 1993;294:829–834
- Aslan M, Kosecik M, Horoz M, et al. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007;191:397–402
- Toker A, Kadi M, Yildirim AK, et al. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 2009;27:176–180
- Usta M, Turan E, Aral H, et al. Serum Paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome. J Clin Lab Anal 2011;25:289–295
- Karakucuk S, Baskol G, Oner AO, et al. Serum paraoxonase activity is decreased in the active stage of Behçet's disease. Br J Ophthalmol 2004;88:1256–1258
- Olsen E, Hordinsky M, Price V, et al. Alopecia areata investigational assessment guidelines – part II. J Am Acad Dermatol 2004;51:440–447
- Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generationmore stable ABTS radical cation. Clin Biochem 2004;37:277–285
- Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–1111
- Bolukbas C, Bolukbas FF, Horoz M, et al. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005;5:95–101
- Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C. 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992;30:391–395
- Sezer E, Ozugurlu F, Ozyurt H, et al. Lipid peroxidation and antioxidant status in lichen planus. Clin Exp Dermatol 2007;32:430–434
- Taysi S, Demircan B, Akdeniz N, et al. Oxidant/antioxidant status in men with Behçet’s disease. Clin Rheumatol 2007;26:418–422
- Koca R, Armutcu F, Altinyazar HC, Gurel A. Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 2004;29:406–409
- Ng CJ, Shih DM, Hama SY, et al. The paraoxonase gene family and atherosclerosis. Free Rad Biol Med 2005;38:153–163
- Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Rad Biol Med 1999;26:892–904